Percutaneous coronary intervention is used to treat patients suffering from an ST-elevation myocardial infarction, where a major artery to the heart is completely blocked. The new percutaneous coronary intervention program will allow patients to be treated on site in the Charles L. Tice Heart Center at the hospital.
“[The program] allows us to provide lifesaving treatments for our local community without delay or need for transport to another facility,” said Gerald Cioce, MD, cardiac catheterization laboratory director at Newton Medical Center. “I am proud of what we have accomplished and pleased to have the opportunity to offer patients this treatment and the associated benefits it brings.”
More articles on cardiology:
Top hospitals for cardiology by state, ranked by US News
Heart transplant program launches at Dell Children’s Medical Center
Please mind the gap: 3 cardiologists discuss disparities in heart care outcomes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.